Hatch's Cosmetics Bill Trades Recall Authority For New 'Adulterated' Language
This article was originally published in The Rose Sheet
Executive Summary
Attorney Angela Diesch says the draft FDA Cosmetic Safety and Modernization Act would lower the burden of proof FDA faces in federal courts when taking action against products it deems dangerous. She views the provision as another compromise between antecedent bills proposed in the House and Senate.
You may also be interested in...
Claire's Scare Revives Concerns About Asbestos-Tainted Kids' Cosmetics
Another retailer of cosmetics aimed at girls, Claire's, faces allegations of asbestos-contaminated makeup products, less than six months after tweens-focused Justice came under similar fire. Both retailers say their own independent testing showed products in question to be asbestos-free, but the PR damage may be done.
Former FDA Cosmetics Director Weighs In On Senator Hatch's Draft FCSMA
Under the draft FDA Cosmetic Safety and Modernization Act, a product could be deemed adulterated "regardless of whether it is known which particular substance or substances may render the cosmetic injurious." EAS Consulting Group's John Bailey offers his perspective on the provision and the overall bill in an exchange with the Rose Sheet.
Former FDA Cosmetics Director Weighs In On Senator Hatch's Draft FCSMA
Under the draft FDA Cosmetic Safety and Modernization Act, a product could be deemed adulterated "regardless of whether it is known which particular substance or substances may render the cosmetic injurious." EAS Consulting Group's John Bailey offers his perspective on the provision and the overall bill in an exchange with the Rose Sheet.